featured
OnabotulinumtoxinA for Pediatric Neurogenic Detrusor Overactivity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurourology and Urodynamics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity in Children
Neurourol Urodyn 2020 Dec 11;[EPub Ahead of Print], PF Austin, I Franco, E Dobremez, P Kroll, W Titanji, T Geib, B Jenkins, PB HoebekeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.